Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater

Abstract Background Adenocarcinoma of the ampulla of Vater (AoV) is one of the rare periampullary cancers, and due to its anatomical location, it is categorized into various histologic subtypes. Its rarity and diversity pose challenges in treatment decision-making for patients with advanced AoV carc...

Full description

Bibliographic Details
Published in:	BMC Cancer
Main Authors:	Seunghwan Lee, Se Jun Park, Kabsoo Shin, Tae Ho Hong, In-Ho Kim, Myung Ah Lee
Format:	Article
Language:	English
Published:	BMC 2024-05-01
Subjects:	Ampulla of vater carcinoma Capecitabine Oxaliplatin Chemotherapy Treatment efficacy
Online Access:	https://doi.org/10.1186/s12885-024-12398-0

Similar Items

Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study
by: Dong Kee Jang, et al.
Published: (2024-07-01)

Conversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report
by: Yo Sato, et al.
Published: (2019-07-01)

Signet ring carcinoma of ampulla of vater
by: Ardeshir Talebi, et al.
Published: (2014-01-01)

Spontaneous Choledochoduodenal Fistula after Metallic Biliary Stent Placement in a Patient with Ampulla of Vater Carcinoma
Published: (2009-12-01)

Prognostic Factors of Ampulla of Vater Carcinoma after Radical Surgery
by: Dongbing ZHAO, et al.
Published: (2009-04-01)

Acute Pancreatitis Following Endoscopic Ampullary Biopsies without Attempted Cannulation of the Ampulla of Vater
by: Spyridon Michopoulos, et al.
Published: (2016-11-01)

Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma
by: Tao Xia, et al.
Published: (2021-02-01)

High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater
by: Takashi Murakami, et al.
Published: (2019-08-01)

Neuroendocrine tumor of the ampulla of Vater treated with endoscopic papillectomy: A case report
by: Koichi Hamada, et al.
Published: (2023-04-01)

An Inflammatory Myofibroblastic Tumor of the Ampulla of Vater Successfully Managed with Endoscopic Papillectomy: Report of a Case
Published: (2010-09-01)

Laparoscopic liver resection after laparoscopic pancreatoduodenectomy for liver metastases of ampulla of Vater adenocarcinoma
by: Muneyasu Kiriyama, et al.
Published: (2020-10-01)

A case of small cell neuroendocrine carcinoma of the ampulla of Vater
by: Hiroharu Ito, et al.
Published: (2020-06-01)

Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer
by: So Jeong Yoon, et al.
Published: (2024-08-01)

Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes
by: G. Perrone, et al.
Published: (2010-09-01)

Post-Metachronous Cancer of the Ampulla of Vater after Gastric Cancer Surgery: An Overview
by: Mehmet Yildirim, et al.
Published: (2022-10-01)

A rare clinical case of a patient with mixed neuroendocrine-non-neuroendocrine neoplasms of the ampulla of vater
by: E. S. Drozdov, et al.
Published: (2023-05-01)

When thoracic trauma does more good than harm: About an incidental finding of a gangliocytic paraganglioma of the ampulla of Vater
by: Guizani Rami, et al.
Published: (2024-12-01)

Mixed neuroendocrine–non-neuroendocrine neoplasm of the ampulla of Vater: a case report
by: Kenjiro Date, et al.
Published: (2023-06-01)

Adenoma viloso da ampola de Vater
by: Julio Cesar Wiederkehr, et al.

Uterine cervix squamous cell carcinoma metastatic to the Ampulla of Vater: a case report with review of the literature
by: Dalma Udovčić Gagula, et al.
Published: (2013-09-01)

Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
by: Akihiko Hatano, et al.
Published: (2023-11-01)

Prognostic Role of Hemoglobin Combined With Geriatric Nutritional Risk Index in Patients With Vater Ampulla Carcinoma Undergoing Pancreaticoduodenectomy
by: Jieping Ying, et al.
Published: (2024-10-01)

A rare case of neuroendocrine cell tumor mixed with a mucinous component in the ampulla of Vater
by: Tamotus Sugai, et al.
Published: (2024-04-01)

Ampulla of Vater carcinoma: advancement in the relationships between histological subtypes, molecular features, and clinical outcomes
by: Hao Liang, et al.
Published: (2023-05-01)

Predictors and Recurrence Patterns After Radical Surgery in Ampulla of Vater Cancer: Comparative Analysis Between Early and Late Recurrence
by: Zheng-Yun Zhang, et al.
Published: (2022-03-01)

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients
by: Dan Kuang, et al.
Published: (2025-07-01)

Invasive micropapillary carcinoma of ampulla of Vater in a young female with negative lymph nodes: A case report and review of literature
by: Manal M S. Elghareeb, et al.
Published: (2023-01-01)

Obstructive Jaundice Caused by Metastatic Neuroendocrine Tumor of the Ampulla of Vater in a Young Adult: A Case Report
by: Jaafar Alsalman, et al.
Published: (2024-04-01)

Readmission rate and complications following biopsy of the ampulla of Vater—A retrospective data analysis
by: Sam Rosella, et al.
Published: (2023-04-01)

Somatostatinoma of the Vater's papilla in a patient with von Recklinghausen's disease
by: Čolović Radoje, et al.
Published: (2007-01-01)

Adenoma viloso com transformação carcinomatosa da ampola de Vater
by: Guilherme Pinto Bravo Neto, et al.

Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater
by: Markus Kapp, et al.
Published: (2016-01-01)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
by: Yuanyuan Yu, et al.
Published: (2021-05-01)

First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
by: Bengang Huo, et al.
Published: (2023-12-01)

Ectopic ampulla with cholangitis: A case report
by: Kiran Shankar, et al.
Published: (2024-10-01)

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
by: Anchuan Li, et al.
Published: (2022-07-01)

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
by: Mohammad Ali Mashhadi, et al.
Published: (2016-10-01)

Cardiotoxicity induced by capecitabine and oxaliplatin in gastric cancer treatment: a rare case of cardiac arrest and cardiogenic shock
by: Muhammad Umer Riaz Gondal, et al.
Published: (2024-03-01)

Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
by: Wanghua Chen, et al.
Published: (2018-08-01)

Efficacy and safety of oxaliplatin and capecitabine in combination with sintilimab as first-line treatment for HER2-negative advanced gastric cancer
by: ZHANG Xiaorui, SHAN Haixia, ZHU Zhengqiu
Published: (2025-01-01)